How a joined-up development strategy pays off for early-stage biotechs

Parexel Biotech’s Nate Akers and Vicky Hsu discuss how important it is for biotechs to align clinical execution with a clearly defined regulatory strategy to increase the chance of success for a new drug program.

Open PDF

Return to Insights Center